Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alcon Inc. stock logo
ALC
Alcon
$93.06
-2.0%
$91.05
$77.54
$101.10
$45.90B1.071.44 million shs203,311 shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$157.12
-5.3%
$159.06
$140.68
$169.99
$378.64B0.479.03 million shs3.09 million shs
STAAR Surgical stock logo
STAA
STAAR Surgical
$17.82
+1.1%
$19.34
$13.50
$52.68
$879.47M0.661.07 million shs20,743 shs
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alcon Inc. stock logo
ALC
Alcon
-0.99%+2.78%+2.55%+11.80%+13.95%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+1.38%+1.51%+0.40%+14.70%+4.87%
STAAR Surgical stock logo
STAA
STAAR Surgical
-0.90%-0.79%+0.74%-27.42%-53.94%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alcon Inc. stock logo
ALC
Alcon
3.391 of 5 stars
3.45.01.70.01.90.81.3
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.4076 of 5 stars
2.33.04.23.93.52.50.6
STAAR Surgical stock logo
STAA
STAAR Surgical
4.4915 of 5 stars
4.02.00.04.13.03.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alcon Inc. stock logo
ALC
Alcon
2.73
Moderate Buy$105.6013.48% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.56
Moderate Buy$171.339.05% Upside
STAAR Surgical stock logo
STAA
STAAR Surgical
2.00
Hold$25.2941.89% Upside

Current Analyst Ratings Breakdown

Latest STAA, ALC, and JNJ Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/31/2025
Alcon Inc. stock logo
ALC
Alcon
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$108.00 ➝ $112.00
3/28/2025
Alcon Inc. stock logo
ALC
Alcon
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$115.00 ➝ $120.00
3/28/2025
Alcon Inc. stock logo
ALC
Alcon
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$107.00 ➝ $110.00
3/25/2025
Alcon Inc. stock logo
ALC
Alcon
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold
3/25/2025
Alcon Inc. stock logo
ALC
Alcon
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
3/25/2025
Alcon Inc. stock logo
ALC
Alcon
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy
3/20/2025
Alcon Inc. stock logo
ALC
Alcon
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$107.00 ➝ $107.00
3/18/2025
STAAR Surgical stock logo
STAA
STAAR Surgical
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight$17.00 ➝ $17.00
3/10/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
3/5/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$159.00 ➝ $171.00
2/27/2025
Alcon Inc. stock logo
ALC
Alcon
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$104.00 ➝ $108.00
(Data available from 4/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alcon Inc. stock logo
ALC
Alcon
$9.91B4.63$5.40 per share17.23$41.81 per share2.23
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$88.82B4.26$12.91 per share12.17$29.69 per share5.29
STAAR Surgical stock logo
STAA
STAAR Surgical
$313.90M2.80$0.77 per share23.02$7.91 per share2.25
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alcon Inc. stock logo
ALC
Alcon
$974M$2.0539.7728.292.2911.89%7.17%5.03%5/12/2025 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$14.07B$6.6523.6314.192.5618.20%34.24%13.63%4/15/2025 (Estimated)
STAAR Surgical stock logo
STAA
STAAR Surgical
-$20.21M-$0.41N/AN/AN/A-6.44%-3.35%-2.67%5/6/2025 (Estimated)

Latest STAA, ALC, and JNJ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/15/2025N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.59N/AN/AN/A$21.65 billionN/A
2/25/2025Q4 2024
Alcon Inc. stock logo
ALC
Alcon
$0.70$0.72+$0.02$0.57$2.47 billion$2.48 billion
1/22/2025Q4 2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$1.99$2.04+$0.05$1.41$22.44 billion$22.52 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alcon Inc. stock logo
ALC
Alcon
$0.260.28%+33.89%12.68%N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.963.16%+5.43%74.59%63 Years
STAAR Surgical stock logo
STAA
STAAR Surgical
N/AN/AN/AN/AN/A

Latest STAA, ALC, and JNJ Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/2/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.43%2/18/20252/18/20253/4/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alcon Inc. stock logo
ALC
Alcon
0.21
2.57
1.60
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.43
1.11
0.86
STAAR Surgical stock logo
STAA
STAAR Surgical
N/A
5.99
5.38

Institutional Ownership

CompanyInstitutional Ownership
Alcon Inc. stock logo
ALC
Alcon
53.86%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
STAAR Surgical stock logo
STAA
STAAR Surgical
96.70%

Insider Ownership

CompanyInsider Ownership
Alcon Inc. stock logo
ALC
Alcon
1.52%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
STAAR Surgical stock logo
STAA
STAAR Surgical
1.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alcon Inc. stock logo
ALC
Alcon
25,200493.24 millionN/AOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
152,7002.41 billion2.40 billionOptionable
STAAR Surgical stock logo
STAA
STAAR Surgical
96049.33 million48.78 millionOptionable

Recent News About These Companies

Staar Surgical shakes up leadership structure

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Alcon stock logo

Alcon NYSE:ALC

$93.06 -1.87 (-1.97%)
As of 10:02 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$157.12 -8.72 (-5.26%)
As of 10:02 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

STAAR Surgical stock logo

STAAR Surgical NASDAQ:STAA

$17.82 +0.19 (+1.08%)
As of 10:01 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.